Home
»
leyu.cim
»
T-cell Therapy Market Size & Share Analysis Report, 2030

T-cell Therapy Market Size, Share & Trends Report

T-cell Therapy Market Size, Share & Trends Analysis Report By Modality, By Therapy (CAR T-cell, Tumor-Infiltrating Lymphocytes), By Indication (Hematologic Malignancies (Lymphoma)), And Segment Forecasts, 2023 - 2030

Report ID: GVR-3-68038-685-1
Number of Pages: 200
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Global T-cell Therapy Market Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- CAR T-cell Therapy
- T Cell Receptor (TCR)-based
- Tumor Infiltrating Lymphocytes (TIL)-based
Global T-cell Therapy Market Process Step Outlook (Revenue, USD Million, 2018 - 2030)
- Hematologic Malignancies
  - Lymphoma
  - Leukemia
  - Myeloma
- Solid Tumors
  - Melanoma
  - Brain & Central Nervous System
  - Liver Cancer
  - Others
- Others
Global T-cell Therapy Market Regional Outlook (Revenue, USD Million; 2018 - 2030)
- North America
  - North America T-cell Therapy Market, By Modality Type, (USD Million)
    - Research
    - Commercialized
  - North America T-cell Therapy Market, By Therapy Type, (USD Million)
    - CAR T-cell Therapy
    - T Cell Receptor (TCR)-based
    - Tumor Infiltrating Lymphocytes (TIL)-based
  - North America T-cell Therapy Market, By Indication, (USD Million)
    - Hematologic Malignancies
      - Lymphoma
      - Leukemia
      - Myeloma
    - Solid Tumors
      - Melanoma
      - Brain & Central Nervous System
      - Liver Cancer
      - Others
    - Others
  - U.S.
    - U.S. T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - U.S. T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - U.S. T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
  - Canada
    - Canada. T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - Canada T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - Canada T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
- Europe
  - Europe T-cell Therapy Market, By Modality Type, (USD Million)
    - Research
    - Commercialized
  - Europe T-cell Therapy Market, By Therapy Type, (USD Million)
    - CAR T-cell Therapy
    - T Cell Receptor (TCR)-based
    - Tumor Infiltrating Lymphocytes (TIL)-based
  - Europe T-cell Therapy Market, By Indication, (USD Million)
    - Hematologic Malignancies
      - Lymphoma
      - Leukemia
      - Myeloma
    - Solid Tumors
      - Melanoma
      - Brain & Central Nervous System
      - Liver Cancer
      - Others
    - Others
  - Germany
    - Germany T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - Germany T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - Germany T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
  - U.K.
    - U.K. T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - U.K. T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - U.K. T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
- Asia Pacific
  - Asia Pacific T-cell Therapy Market, By Modality Type, (USD Million)
    - Research
    - Commercialized
  - Asia Pacific T-cell Therapy Market, By Therapy Type, (USD Million)
    - CAR T-cell Therapy
    - T Cell Receptor (TCR)-based
    - Tumor Infiltrating Lymphocytes (TIL)-based
  - Asia Pacific T-cell Therapy Market, By Indication, (USD Million)
    - Hematologic Malignancies
      - Lymphoma
      - Leukemia
      - Myeloma
    - Solid Tumors
      - Melanoma
      - Brain & Central Nervous System
      - Liver Cancer
      - Others
    - Others
  - China
    - China T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - China T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - China T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
  - Japan
    - Japan T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - Japan T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - Japan T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
  - India
    - India T-cell Therapy Market, By Modality Type, (USD Million)
      - Research
      - Commercialized
    - India T-cell Therapy Market, By Therapy Type, (USD Million)
      - CAR T-cell Therapy
      - T Cell Receptor (TCR)-based
      - Tumor Infiltrating Lymphocytes (TIL)-based
    - India T-cell Therapy Market, By Indication, (USD Million)
      - Hematologic Malignancies
        
        Lymphoma
        
        Leukemia
        
        Myeloma
      - Solid Tumors
        
        Melanoma
        
        Brain & Central Nervous System
        
        Liver Cancer
        
        Others
      - Others
- Rest Of The World
  - Rest Of The World T-cell Therapy Market, By Modality Type, (USD Million)
    - Research
    - Commercialized
  - Rest Of The World T-cell Therapy Market, By Therapy Type, (USD Million)
    - CAR T-cell Therapy
    - T Cell Receptor (TCR)-based
    - Tumor Infiltrating Lymphocytes (TIL)-based
  - Rest Of The World T-cell Therapy Market, By Indication, (USD Million)
    - Hematologic Malignancies
      - Lymphoma
      - Leukemia
      - Myeloma
    - Solid Tumors
      - Melanoma
      - Brain & Central Nervous System
      - Liver Cancer
      - Others
    - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.